Mersana Therapeutics IncNASDAQ:MRSN
- LAST PRICE1.8100
- TODAY'S CHANGE (%)-0.0600 (-3.2086%)
- Bid / Lots1.7400/ 10
- Ask / Lots1.9300/ 12
- Open / Previous Close1.8700 / 1.8700
- Day Range
- 52 Week Range
- Volume419,099
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MRSN |
|---|---|---|
| 09:32 ET | 2466 | 1.85 |
| 09:34 ET | 7018 | 1.85 |
| 09:38 ET | 2777 | 1.85 |
| 09:41 ET | 1680 | 1.86 |
| 09:48 ET | 200 | 1.85 |
| 09:52 ET | 10842 | 1.845 |
| 09:54 ET | 700 | 1.85 |
| 09:56 ET | 1150 | 1.85 |
| 09:57 ET | 2000 | 1.85 |
| 09:59 ET | 23148 | 1.85 |
| 10:01 ET | 6350 | 1.8499 |
| 10:03 ET | 2357 | 1.85 |
| 10:06 ET | 709 | 1.85 |
| 10:08 ET | 16043 | 1.84 |
| 10:10 ET | 6286 | 1.845 |
| 10:12 ET | 3000 | 1.86 |
| 10:14 ET | 1300 | 1.865 |
| 10:15 ET | 869 | 1.87 |
| 10:17 ET | 1200 | 1.8807 |
| 10:19 ET | 1501 | 1.895 |
| 10:21 ET | 500 | 1.89 |
| 10:24 ET | 3678 | 1.885 |
| 10:26 ET | 300 | 1.885 |
| 10:28 ET | 300 | 1.88 |
| 10:30 ET | 300 | 1.875 |
| 10:32 ET | 800 | 1.86 |
| 10:33 ET | 400 | 1.87 |
| 10:35 ET | 600 | 1.865 |
| 10:42 ET | 741 | 1.86 |
| 10:48 ET | 100 | 1.855 |
| 10:50 ET | 198 | 1.855 |
| 11:00 ET | 22368 | 1.85 |
| 11:02 ET | 1367 | 1.85 |
| 11:04 ET | 700 | 1.85 |
| 11:06 ET | 600 | 1.85 |
| 11:08 ET | 3427 | 1.845 |
| 11:09 ET | 1783 | 1.854 |
| 11:11 ET | 411 | 1.855 |
| 11:13 ET | 100 | 1.855 |
| 11:20 ET | 1140 | 1.85 |
| 11:24 ET | 1712 | 1.855 |
| 11:26 ET | 2830 | 1.859 |
| 11:27 ET | 1088 | 1.855 |
| 11:29 ET | 548 | 1.855 |
| 11:31 ET | 1788 | 1.85 |
| 11:33 ET | 100 | 1.85 |
| 11:36 ET | 100 | 1.85 |
| 11:38 ET | 700 | 1.855 |
| 11:47 ET | 400 | 1.853057 |
| 11:49 ET | 100 | 1.85 |
| 11:51 ET | 100 | 1.85 |
| 11:54 ET | 2482 | 1.85 |
| 11:56 ET | 4388 | 1.855 |
| 11:58 ET | 9883 | 1.8475 |
| 12:00 ET | 8419 | 1.85 |
| 12:02 ET | 6400 | 1.855 |
| 12:03 ET | 400 | 1.855 |
| 12:05 ET | 2362 | 1.86 |
| 12:18 ET | 100 | 1.86 |
| 12:20 ET | 100 | 1.86 |
| 12:21 ET | 5888 | 1.87 |
| 12:23 ET | 3086 | 1.865 |
| 12:27 ET | 300 | 1.86 |
| 12:30 ET | 100 | 1.86 |
| 12:32 ET | 100 | 1.86 |
| 12:34 ET | 100 | 1.86 |
| 12:36 ET | 1405 | 1.864 |
| 12:38 ET | 600 | 1.855 |
| 12:41 ET | 100 | 1.855 |
| 12:48 ET | 100 | 1.855 |
| 12:50 ET | 407 | 1.855 |
| 12:52 ET | 400 | 1.855 |
| 12:54 ET | 15162 | 1.84 |
| 12:56 ET | 1300 | 1.8475 |
| 12:57 ET | 868 | 1.85 |
| 12:59 ET | 2256 | 1.85 |
| 01:01 ET | 1512 | 1.85 |
| 01:03 ET | 1600 | 1.85 |
| 01:10 ET | 267 | 1.8599 |
| 01:14 ET | 5515 | 1.855 |
| 01:15 ET | 334 | 1.855 |
| 01:19 ET | 1100 | 1.86 |
| 01:24 ET | 300 | 1.86 |
| 01:28 ET | 113 | 1.87 |
| 01:30 ET | 800 | 1.86 |
| 01:32 ET | 100 | 1.85 |
| 01:44 ET | 208 | 1.85 |
| 01:51 ET | 9045 | 1.855 |
| 01:53 ET | 200 | 1.855 |
| 01:55 ET | 1500 | 1.86 |
| 02:09 ET | 100 | 1.86 |
| 02:13 ET | 300 | 1.865 |
| 02:18 ET | 100 | 1.865 |
| 02:20 ET | 1040 | 1.86 |
| 02:27 ET | 100 | 1.855 |
| 02:29 ET | 200 | 1.85 |
| 02:33 ET | 300 | 1.855 |
| 02:36 ET | 100 | 1.85 |
| 02:38 ET | 21878 | 1.85 |
| 02:44 ET | 1052 | 1.8508 |
| 02:45 ET | 200 | 1.85 |
| 02:51 ET | 100 | 1.85 |
| 02:54 ET | 300 | 1.85 |
| 02:56 ET | 1547 | 1.855 |
| 02:58 ET | 100 | 1.85 |
| 03:02 ET | 200 | 1.85 |
| 03:03 ET | 339 | 1.85 |
| 03:05 ET | 300 | 1.855 |
| 03:14 ET | 200 | 1.855 |
| 03:16 ET | 196 | 1.855 |
| 03:23 ET | 500 | 1.855 |
| 03:25 ET | 200 | 1.855 |
| 03:27 ET | 100 | 1.855 |
| 03:30 ET | 899 | 1.85 |
| 03:34 ET | 100 | 1.84 |
| 03:43 ET | 317 | 1.84 |
| 03:45 ET | 1300 | 1.85 |
| 03:48 ET | 300 | 1.845 |
| 03:50 ET | 285 | 1.845 |
| 03:52 ET | 488 | 1.84 |
| 03:54 ET | 714 | 1.845 |
| 03:56 ET | 1300 | 1.845 |
| 03:57 ET | 8104 | 1.835 |
| 03:59 ET | 97906 | 1.81 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mersana Therapeutics Inc | 229.4M | -2.1x | --- |
Nanobiotix SA | 201.9M | -3.6x | --- |
Artiva Biotherapeutics Inc | 246.5M | 0.0x | --- |
Caribou Biosciences Inc | 178.0M | -1.4x | --- |
Compugen Ltd | 146.8M | -14.9x | --- |
TScan Therapeutics Inc | 250.6M | -4.3x | --- |
Company Information
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is focused on the development of antibody-drug conjugates (ADCs), which offer a clinically meaningful benefit for cancer patients with significant unmet needs. It has developed two proprietary and differentiated ADC platforms: Dolasynthen and Immunosynthen. Dolasynthen is its cytotoxic ADC platform that is designed to generate site-specific, homogeneous ADCs. Immunosynthen is its proprietary stimulator of interferon genes (STING)-agonist platform that is designed to generate systemically administered ADCs that locally activate STING signaling in both antigen-expressing tumor cells and in tumor-resident immune cells. The Company's pipeline also includes XMT-1660, a Dolasynthen ADC targeting B7-H4 in a Phase I clinical trial, and XMT-2056, an Immunosynthen ADC targeting a novel epitope of human epidermal growth factor receptor 2 (HER2), in addition to other earlier-stage assets.
Contact Information
- Headquarters
- 840 Memorial DrCAMBRIDGE, MA, United States 02139-3789
- Phone
- 617-498-0020
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- David Mott
- President, Chief Executive Officer, Director
- Martin Huber
- Chief Financial Officer, Chief Operating Officer, Senior Vice President
- Brian Deschuytner
- Senior Vice President, Chief Science and Technology Officer
- Timothy Lowinger
- Senior Vice President, Chief Development Officer
- Mohan Bala
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $229.4M |
|---|---|
Revenue (TTM) | $29.9M |
Shares Outstanding | 122.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.47 |
EPS | $-0.86 |
Book Value | $0.31 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | 7.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -373.53% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
